Dr. Keith A. Choate, MD, PhD

Dr. Choate practices at Yale Medicine in New Haven, Connecticut.

Dr. Choate's NPI, 1609058080, was assigned on November 28, 2007. Dr. Choate graduated from Yale School of Medicine in 2004. Dr. Choate's Connecticut license number on file is 045905.

Dr. Choate's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Choate's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Choate is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Choate to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Choate practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Choate's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Choate is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Choate's licenses on file in 2 states: Connecticut and Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, psoriasis, rash and scalp rash among the conditions Dr. Choate treats.

CMS data shows 711 Medicare services from Dr. Choate across 6 procedure codes in 2024, for 122 Medicare patients. Medicare paid $26,826 for them. Every service was in an office.

CMS counts 122 Medicare patients who saw Dr. Choate in 2024. The largest group is 75 to 84, with 51 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Choate's median patient age at 71, with 41% women.

In 2024, Dr. Choate wrote 749 Medicare Part D claims for 149 patients. 69% of them were for generic drugs. CMS names the drug for 619 of them, across 26 drugs with 11 or more claims each, at $1,630,205 in total drug cost. In 2023, CMS named 743 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Choate for performance year 2024, reported as part of a group. Dr. Choate accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 181 procedures of removal of skin lesions by Dr. Choate, more than 79% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 127 papers to Dr. Choate, published from 2002 to 2025. 2020 was the busiest year, with 10. The most frequent topics are Phenotype, Skin and Ichthyosis. Dr. Choate has published most often in J Invest Dermatol. Dr. Choate's most frequent co-authors are Brittany Craiglow, MD, Richard J. Antaya, MD and Leonard M. Milstone, MD.

Dmand AI links Dr. Choate to 1 clinical trial. Conditions studied include Ichthyosiform Erythroderma, Congenital and Ichthyosis, Lamellar.

CMS Open Payments shows 699 general payments to Dr. Choate from 11 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 88% of the total. Janssen Pharmaceuticals, Inc paid the most, $449,791.

Dmand AI lists 2 awards for Dr. Choate, most recently CMS Stage 1 EHR in 2013.

Dr. Choate graduated from Yale School of Medicine in 2004. Dr. Choate is a member of AAD.

Dr. Choate is in network with 9 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Cigna. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.